Mosaic HIV-1 vaccines expand the breadth and depth of cellular immune responses in rhesus monkeys. - Wikidata - awgldk - TriplyDB

Mosaic HIV-1 vaccines expand the breadth and depth of cellular immune responses in rhesus monkeys.

Mosaic HIV-1 vaccines expand the breadth and depth of cellular immune responses in rhesus monkeys.

http://www.wikidata.org/entity/Q33712578

about

Vaccines: from empirical development to rational design Emerging targets and novel approaches to Ebola virus prophylaxis and treatment HIV-1 prophylactic vaccines: state of the art HIV-Host Interactions: Implications for Vaccine Design Can immunotherapy be useful as a "functional cure" for infection with Human Immunodeficiency Virus-1?The future of HIV vaccine research and the role of the Global HIV Vaccine Enterprise A global approach to HIV-1 vaccine development High avidity CD8+ T cells efficiently eliminate motile HIV-infected targets and execute a locally focused program of anti-viral function Progress in HIV-1 vaccine development.New concepts in HIV-1 vaccine development Perspectives for immunotherapy: which applications might achieve an HIV functional cure?The Number and Complexity of Pure and Recombinant HIV-1 Strains Observed within Incident Infections during the HIV and Malaria Cohort Study Conducted in Kericho, Kenya, from 2003 to 2006 Measurements of immune responses for establishing correlates of vaccine protection against HIV Increased breadth and depth of cytotoxic T lymphocytes responses against HIV-1-B Nef by inclusion of epitope variant sequences Epigraph: A Vaccine Design Tool Applied to an HIV Therapeutic Vaccine and a Pan-Filovirus Vaccine Broad protection against avian influenza virus by using a modified vaccinia Ankara virus expressing a mosaic hemagglutinin gene Low seroprevalent species D adenovirus vectors as influenza vaccines.Current views on the potential for development of a HIV vaccine.Defining epitope coverage requirements for T cell-based HIV vaccines: theoretical considerations and practical applications.Vaccine design for CD8 T lymphocyte responses Human immunodeficiency virus vaccine trials HIV-1 Vaccine Trials: Evolving Concepts and Designs A human immune data-informed vaccine concept elicits strong and broad T-cell specificities associated with HIV-1 control in mice and macaques.Altered response hierarchy and increased T-cell breadth upon HIV-1 conserved element DNA vaccination in macaques.HIV-1 vaccines: challenges and new perspectives Induction of Potent and Long-Lived Antibody and Cellular Immune Responses in the Genitorectal Mucosa Could be the Critical Determinant of HIV Vaccine Efficacy.Novel directions in HIV-1 vaccines revealed from clinical trials Transmission of single HIV-1 genomes and dynamics of early immune escape revealed by ultra-deep sequencing.Hurdles to the Development of Effective HBV Immunotherapies and HCV Vaccines Intra- and inter-clade cross-reactivity by HIV-1 Gag specific T-cells reveals exclusive and commonly targeted regions: implications for current vaccine trials Characterization and immunogenicity of a novel mosaic M HIV-1 gp140 trimer The influence of delivery vectors on HIV vaccine efficacy Analysis of high-depth sequence data for studying viral diversity: a comparison of next generation sequencing platforms using Segminator II.HIV-1 subtype distribution in the Gambia and the significant presence of CRF49_cpx, a novel circulating recombinant form.Novel adenovirus vector-based vaccines for HIV-1.New approaches to design HIV-1 T-cell vaccines Potent and broadly reactive HIV-2 neutralizing antibodies elicited by a vaccinia virus vector prime-C2V3C3 polypeptide boost immunization strategy.Early selection in Gag by protective HLA alleles contributes to reduced HIV-1 replication capacity that may be largely compensated for in chronic infection HIV vaccines: lessons learned and the way forward.The effect of HLA polymorphisms on the recognition of Gag epitopes in HIV-1 CRF01_AE infection.

P2860

Q21089599-E7F5A632-8371-48FD-9F10-6351B5686796 Q24597625-572C69ED-509E-4879-8523-63FAD297C716 Q26740042-9FD9305B-602B-4921-BF45-0F4A915AA8FF Q26765966-52DABBEA-7F1A-4A8F-B9B7-D41ABD51674C Q26865388-64238F1D-553D-49FA-9533-02B218AA4807 Q27010375-5329E4F0-CB33-44F2-825C-785FDD853143 Q27024614-D697BF20-3D13-4010-8ACE-F585E82DAF69 Q27323727-79ADA6B1-4913-44FB-938D-878F1279142A Q27693849-D5E72AE2-E167-4A16-A095-F9598E666314 Q28067027-AB488F9D-5CBF-42EB-960E-28DAE369B1EC Q28078726-A4A84068-5EBA-4649-B68E-91DF28A5887D Q28608652-427F1D73-099B-44D2-B312-C3F4F4827711 Q28728189-04F9F0AC-EA5F-4784-B88C-93ACEAD9363F Q28741616-122FB23B-F422-40D1-B922-FCF4ED51C63B Q28822525-E4C9CBED-F814-444C-8C16-AC3DF66B0D87 Q30207890-E300CD6F-E40A-4449-961E-EE63A283AC1B Q30353263-340C69AC-4498-455B-A929-2A2204EA4171 Q30397595-9F2464FC-53F4-4738-A23C-93639769E36E Q30410411-CC297E54-C516-42D9-A1EF-26797A1AF013 Q30411492-ECA6416C-EFFC-40C7-9629-989E52F72CEA Q30424366-4D8BEA05-B3CD-4000-BACE-1F8269D779EB Q30425520-F3D902E9-A430-43C6-B906-E159D330403E Q30934059-F8FAF826-0779-4F74-89D4-EDC200AB85FF Q31148797-635B75BD-6171-4330-B0B0-2C00DF4E6C80 Q33577972-0D968D4F-FCAA-408E-914C-1CE7A1F0FB15 Q33611645-03C42C62-B628-4F4E-A0DE-667D678495BD Q33645528-9130BA87-E9B0-474A-BDFA-40D238A33066 Q33680395-58F4F9E2-A042-4A8C-BE6D-D9FBF5BEACD4 Q33840260-01BAE68D-C587-444B-B82A-BCA2E8EAD80F Q34055991-584CC905-39ED-42AE-A5A0-D8C1F4A008A5 Q34059543-CAF8E9B3-6A65-4191-9B88-5AF4D78249A3 Q34077543-036D1C17-4EE6-4386-8C4E-701B9C7B1D7E Q34207464-1E16315B-BF3E-4FB9-9003-888AC35A0A25 Q34243456-FC1E05B4-A425-45B4-9D45-D253794F6865 Q34257640-ACBE61F1-02F3-441E-8CB2-714839AD5D65 Q34274849-ACB1BF94-FB56-4976-94DB-068955059BC2 Q34290973-9D0609C9-7B66-4447-A262-777CB65E1EF0 Q34295972-EE52CFD7-24BA-409F-B26B-4F5F3CADD29C Q34342558-145A1586-4491-4A68-988B-4475A8690E2A Q34358831-0454764B-C8BD-4283-B35A-DB63DEA05F40

P2860

Mosaic HIV-1 vaccines expand the breadth and depth of cellular immune responses in rhesus monkeys.

http://www.wikidata.org/entity/Q33712578

description

2010 nî lūn-bûn

@nan

2010 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Mosaic HIV-1 vaccines expand t ...... e responses in rhesus monkeys.

@ast

Mosaic HIV-1 vaccines expand t ...... e responses in rhesus monkeys.

@en

type

label

Mosaic HIV-1 vaccines expand t ...... e responses in rhesus monkeys.

@ast

Mosaic HIV-1 vaccines expand t ...... e responses in rhesus monkeys.

@en

prefLabel

Mosaic HIV-1 vaccines expand t ...... e responses in rhesus monkeys.

@ast

Mosaic HIV-1 vaccines expand t ...... e responses in rhesus monkeys.

@en

P1433

Q33712578-A529A60A-713D-41B2-AE40-3F79B76D4B38

P1476

Q33712578-1AE5A786-2166-499A-8923-8CA86A64ED0C

P2093

Q33712578-340388AA-4979-44E6-9137-F85385832F45

Q33712578-49530B17-986E-4B7A-8B23-EE980A7D6C89

Q33712578-5B3F0388-D0C2-4379-A5E9-6E3252DE8E4E

Q33712578-771985AA-01D6-4D0C-9790-D643110BD4C1

Q33712578-88C229F6-FF62-42C7-8CFA-A4D5464535DE

Q33712578-95991341-8A4D-46F7-B43A-67156798433E

Q33712578-B1FEE0AC-2DF4-4A69-9BB9-9150B61CBE24

Q33712578-B48A222E-5052-4E7F-912E-93A9D1385129

Q33712578-B938B82C-C020-4498-AE69-4BD68AF70F5D

Q33712578-BF1C41F0-9882-4F2F-B077-C7FE62F69BE0

P2860

Q33712578-047C15B5-8040-46D4-89F3-7F9C412EB228

Q33712578-208D7E82-8BAB-4767-BA75-1363408D38B6

Q33712578-33843EA8-AA2D-4BCA-8992-174554BB2098

Q33712578-3FC395D8-7C1D-4EFE-ACE3-EA47F616A688

Q33712578-4862A0DC-0BDD-4418-8A9B-8258EEBB03F7

Q33712578-5F3179C4-E87C-426F-8E3C-A7B7AE4D77A7

Q33712578-6523638E-07E7-4D33-8960-B2B080CE16CF

Q33712578-8101A9D3-1B98-4F6B-9FA9-CB94AB092E1E

Q33712578-8A155F80-B676-4F99-BCB8-13CFBE464B5E

Q33712578-912FE4C0-84B3-4A07-A9A5-C23D74340104

P2888

Q33712578-FC19C21B-3A6A-4508-B56A-76B28569660E

P304

Q33712578-AD946D8E-B096-4CB3-A39B-76BFDAE6588E

P31

Q33712578-53066F5C-6549-4B07-9123-4A8B96539653

P356

Q33712578-B9299C57-F2A8-440A-8BFB-22FA7BB9AA6C

P407

Q33712578-2600FD65-2674-4616-AA4B-7BE9A9342716

P433

Q33712578-C9BD39F1-EDEB-4403-B64B-7789A1C7260C

P478

Q33712578-3DBA2651-31ED-42F6-B8F5-F67BDFD37335

P50

Q33712578-118C1CEF-4407-4E26-9682-D99342555E03

Q33712578-29A534C9-600A-45FA-AB3C-A546B3974B23

Q33712578-4784C8F6-F385-48D9-8973-8C34F028F35F

Q33712578-6339CB2A-F9D4-4EF2-8670-FEC1F9595AB1

Q33712578-63DA4DBA-9FD2-4B93-A909-E9188212F598

Q33712578-691F757D-AAC8-4FD8-A563-869522B8A40B

Q33712578-B3DA7F04-6283-4393-9B44-658D9DB16A2D

P577

Q33712578-AAE051AE-2A02-4A4D-881B-24CCC8862A93

P5875

Q33712578-4A0DAD71-E239-4AA6-8392-6735E330852D

P6179

Q33712578-542CA23F-11E7-4A0D-AF77-C3183E595F16

P698

Q33712578-341B43F5-8CB8-4AFC-91C1-6E8FE9FADD7B

P932

Q33712578-D60E9E5B-8D53-453B-AD72-E9BA5F8E72C5

P356

P1433

Nature Medicine

P1476

Mosaic HIV-1 vaccines expand t ...... e responses in rhesus monkeys.

@en

P2093

Ambryice M Riggs

http://www.w3.org/2001/XMLSchema#string

Angela Carville

http://www.w3.org/2001/XMLSchema#string

Annalena La Porte

http://www.w3.org/2001/XMLSchema#string

Diana M Lynch

http://www.w3.org/2001/XMLSchema#string

James J Szinger

http://www.w3.org/2001/XMLSchema#string

James R Perry

http://www.w3.org/2001/XMLSchema#string

Kara L O'Brien

http://www.w3.org/2001/XMLSchema#string

Katherine Backus

http://www.w3.org/2001/XMLSchema#string

Keith G Mansfield

http://www.w3.org/2001/XMLSchema#string

Michael S Seaman

http://www.w3.org/2001/XMLSchema#string

P2860

Toward an AIDS vaccine: lessons from natural simian immunodeficiency virus infections of African nonhuman primate hosts

Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial

Challenges in the development of an HIV-1 vaccine.

Comparative seroprevalence and immunogenicity of six rare serotype recombinant adenovirus vaccine vectors from subgroups B and D

A centralized gene-based HIV-1 vaccine elicits broad cross-clade cellular immune responses in rhesus monkeys.

Expanded breadth of the T-cell response to mosaic human immunodeficiency virus type 1 envelope DNA vaccination

The first T cell response to transmitted/founder virus contributes to the control of acute viremia in HIV-1 infection.

T-cell vaccine strategies for human immunodeficiency virus, the virus with a thousand faces.

HIV-1 vaccine-induced immunity in the test-of-concept Step Study: a case-cohort analysis.

Evaluating neutralizing antibodies against HIV, SIV, and SHIV in luciferase reporter gene assays.

P2888

P304

319-323

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NM.2089

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

16

http://www.w3.org/2001/XMLSchema#string

P50

Nathaniel Simmons

Lori F Maxfield

P577

2010-02-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

41510455

http://www.w3.org/2001/XMLSchema#string

P6179

1033531216

http://www.w3.org/2001/XMLSchema#string

P698

20173752

http://www.w3.org/2001/XMLSchema#string

P932

2834868

http://www.w3.org/2001/XMLSchema#string